Table 1. Preliminary SAR of X, R6, and R3 Substituents.
R3 | R6 | X | Kd-appa (μM) | IC50b (μM) | EC50c (μM) | CC50d (μM) | |
---|---|---|---|---|---|---|---|
1 | H | Cl | H | 9.1 | >40 | ||
2 | H | Br | H | 5.1 | >33 | ||
3 | H | H | H | 24 | |||
4 | H | Br | Me | 0.35 | 20 | ||
5 | H | Br | Cl | 0.27 | 16 | >64 | |
6 | H | H | Cl | 3.1 | >43 | ||
7 | Me | Br | Cl | 0.31 | 13 | ||
8 | n-Pr | Br | Cl | 0.077 | 0.92 | 94 | |
9 | OMe | Br | Cl | 0.040 | 0.99 | >64 | |
10 | (R)-OMe | Br | Cl | 3.1 | 47 | ||
11 | (S)-OMe | Br | Cl | 4.7 | 0.028 | 0.45 | >51 |
12 | (S)-Oi-Pr | Br | Cl | 0.28 | 0.13 | >50 | |
13 | (S)-Ot-Bu | Br | Cl | 0.15 | 0.078 | >5 |
Kd-app determined using displacement assay.
IC50 determined with LTR-cleavage assay.
EC50 determined with HxB2 virus (A124/T125 IN variant).
CC50 determined as previously described (see ref (18)).